Interim Report January – March 2023
ChromoGenics delivers to Denmark and begins cooperation in FranceQ1 2023 In Q1 2023, ChromoGenics’ net sales amounted to SEK 5.8 (8.5) million, a decrease of SEK 2.7 million compared to the corresponding quarter in 2022. The company made deliveries during the first quarter to, among others, Franska Skolan in Copenhagen, Denmark, which impacted net sales by SEK 2.5 million during the quarter. ChromoGenics’ operating loss for the first quarter of the year amounted to SEK -12.2(-16.8) million, which is an improvement of SEK 4.6 million compared to the corresponding period in 2022. The